New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

These segments include drug class, diabetes type, route of administration, and distribution channels, each playing a critical role in addressing the varied needs of individuals managing diabetes.

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Nov. 11, 2024 DALLAS, Nov. 11, 2024 — GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

GLP-1 medications, such as Ozempic, may interact with other drugs, causing very low blood sugar levels or disrupting the ...

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.